Coinfection
Meeting category
Date(s)
16 May 2018 - 18 May 2018
Location
Seville, Spain

International Workshop on Co-infection: HIV, Hepatitis, and Liver Disease 2018

Related Enduring Materials

Enduring Materials

Pre-Workshop Educational Course

Day 1 - Wednesday, 16 May 2018

- 09:30
09:30 CEST
HCV in 2018
Jürgen Rockstroh, MD
University of Bonn, Germany
09:55 CEST
HBV: diagnostics, management and screening
Marion Peters, MD
Northwestern University, United States
11:05 CEST
Liver care in HIV - management of abnormal LFTs
Juan Berenguer
Juan Berenguer, MD, PhD
Hospital General Universitario Gregorio Marañón, Madrid, Spain
11:30 CEST
NAFLD: diagnostics, management and screening
Juan Macías
Juan Macías, MD, PhD
Hospital de Valme, Seville, Spain
11:50 CEST
Fibrosis Markers and Cirrhosis management in HIV patients
Marion Peters, MD
Northwestern University, United States

International Workshop on Co-infection: HIV, Hepatitis, and Liver Disease 2018

Session 1: Management of Hepatitis C - part 1 - 14:05
14:05 CEST
DAA: will generics change the landscape?
Sabela Lens
Sabela Lens, MD
Institut d'Investigacions Biomèdiques August Pi i Sunyer, Barcelona, Spain
14:35 CEST
Abstract - driven presentations
-
Response to Sofosbuvir/Ledipasvir for 8 or 12 Weeks in HCV-Monoinfected and HIV/HCV-Coinfected Patients in Clinical Practice
Anaïs Corma
-
-
Real-life Results of Grazoprevir/Elbasvir in HCV-Infected PWID: The Zepalive Study
Juan Macías
-
-
Baseline Resistance-Guided Therapy Does Not Enhance the Response to Interferon-Free Treatment of HCV Infection in Real Life
Luis M. Real
-
16:30 CEST
Industry-sponsored Symposium

Day 2 - Thursday, 17 May 2018

Session 2: Management of Hepatitis C - part 2 - 09:00
09:00 CEST
HCV care after cure
Raffaele Bruno
Raffaele Bruno, MD
University of Pavia, Italy
09:30 CEST
Abstract - driven presentations
-
A Comparison of Single and Multiple Tablet Regiments for the Treatment of HCV Infection Among HIV Co-Infected Individuals
Astou Thiam
-
-
Long-Term Changes of Liver Stiffness After the Use of All Oral DAA Regimens
Nicolás Merchante
-
-
Follow-Up of Sustained Virologic Responders with Hepatitis C/HIV Coinfection and Advanced Liver Disease
C. Soeiro
-
Session 3: Management of Hepatitis B - part 1 - 11:00
11:00 CEST
HBV managment in HIV patients
Karine Lacombe, MD, PhD
Hôpital Saint Antoine Paris, France
11:25 CEST
HBV Novel Therapies
Maria Buti
Maria Buti, MD, PhD
Hospital Universitario Valle Hebron, Barcelona, Spain
Session 4: Best of Posters - 12:05
12:05 CEST
6-8 Best of Posters
-
Hepatitis C Diagnostic - Barrier to Effective Linkage to Care within Georgian Hepatitis C Elimination Program
Guranda Jikia, MD, MPH
-
-
Epidemiological Characteristics and Factors Contributing to the Development of Liver Fibrosis in HIV/HCV-Coinfected Patients in Ukraine
T. Kyrychenko
-
-
Characterization of Patients Treated with Hepatitis C - is HIV a Burden? Analysis of an Individual Experience
Cristina Valente
-
-
Decrease in HCV Coinfection in Individuals Newly Diagnosed with HIV-1 in Germany, January 2016 - December 2017
Patrycja Machnowska
-
Session 5: Management of Hepatitis B - part 2 - 14:00
14:00 CEST
Debate: TDF vs. TAF in HBV management
Mark Nelson, MA, MBBS, FRCP
Chelsea and Westminster Hospital / Imperial College Medical School, United Kingdom
Douglas Dieterich, MD
Mount Sinai Medical Centre, New York, NY, USA
14:35 CEST
Case on HEV
Antonio Rivero-Juarez
Antonio Rivero-Juarez, PhD
Hospital Universitario Reina Sofia, Cordoba, Spain
Session 6: NAFLD and HIV - 15:35
15:35 CEST
NAFLD in HIV- infected patients
Juan Macías
Juan Macías, MD, PhD
Hospital de Valme, Seville, Spain
16:00 CEST
Abstract - driven presentations
-
Expression of Immunological Markers in Inflammatory Infiltrate Cells of Liver in Patients with HIV/HIV Coinfection
N. Matsiyeuskaya
-
-
Failure Rate of Ultrasound Surveillance of Hepatocellular Carcinoma in HIV+ Patients
Nicolás Merchante
-
-
CD4-T Cell and Metabolic Changes adter DAAs: a Multicenter Study
L.A. Nicolini
-

Day 3 - Friday, 18 MAY 2018

Session 7: Fibrosis markers in liver disease - 09:00
09:00 CEST
The role of Fibroscan: pre and post SVR
Nicolás Merchante
Nicolás Merchante, MD
Hospital de Valme, Seville, Spain
09:25 CEST
Abstract - driven presentations
-
Hapatitis C Reinfection after Sustained Virological Response in HIV/HCV Co-Infected Patients
Fábio Videira Santos
-
Session 8: Hepatitis A in HIV - 10:30
10:30 CEST
Roundtable Discussion: Hepatitis A in HIV: the French, Italian, and Spanish Perspective
Massimo Puoti, MD
University MIlano Bicocca School of Medicine - ASST Great Metropolitan Hospital Niguarda Milan, Italy
Luz Martin-Carbonero
Luz Martin-Carbonero, MD, PhD
Hospital Universitario La Paz, Madrid, Spain
11:15 CEST
Epidemiology, diagnostics and treatment of Hepatitis E
-
HAV in a Tertiary Hospital: 2017 Epidemic vs 2009-2016 Period
Andrea Lombardi, MD
-
Overview
Welcome

We would like to thank all of the 120 participants of the 14th edition of the International Workshop on Co-infection: HIV, Hepatitis, and Liver Disease (16 - 18 May 2018, Seville) for their invaluable contribution in making this meeting such a success.

On behalf of the Organizing Committee, we would also like to express our gratitude to ViiV Healthcare and Gilead for their generous support. 

Committees
Organizing Committee

The members of the Organizing Committee (OC) are a group of carefully selected experts and inspirational leaders in their respective fields. They come together on a frequent basis to discuss the scientific program of the workshop, identify interesting topics and candidate speakers and review all submitted abstracts. 

Rui Sarmento e Castro
Rui Sarmento e Castro, MD, PhD
-
Massimo Puoti, MD
Massimo Puoti, MD
University MIlano Bicocca School of Medicine - ASST Great Metropolitan Hospital Niguarda Milan, Italy
Kenneth Sherman
Kenneth Sherman, MD, PhD
-
placeholder3
Vicente Soriano, MD, PhD
-
Scientific Committee

The members of Scientific Committee assist the Organizing Committee by providing them with suggestions for speakers and topics. In addition, members of the Scientific Committee participate in reviewing submitted abstracts, and play an active role during the workshop as moderators and/or chairs of sessions.

  • Sanjay Bhagani - Royal Free London NHS Foundation Trust, UK
  • Raffaele Bruno - University of Pavia, Italy
  • Giampiero Carosi - University of Brescia, Italy
  • Andy Hoepelman - UMC Utrecht, Netherlands
  • Andrzej Horban - Hospital for Infectious Diseases, Poland
  • Patrick Ingiliz - Medical Center for Infectious Diseases, Germany
  • Arthur Kim - Massachusetts General Hospital, USA
  • Marina Klein - McGill University Health Centre, Canada
  • Sharon Lewin - Monash University Alfred Hospital, Australia
  • Juan A. Pineda - Hospital de Valme, Spain
  • Stanislas Pol - Hôpital Cochin, France
  • Giuliano Rizzardini - University of Milan,Italy
  • Dominique Salmon - Hopital Cochin, France
  • Ulrich Spengler - University of Bonn, Germany
  • Cristina Tural - Hospital Germans Trias i Pujol, Spain
Support
Endorsers